U.S., Jan. 28 -- An application to own the trademark for 'AGF' has been filed on Aug. 13, 2025.
Owner(s):
XenImmune Therapeutics; One Kendall Square, Bldg 300, , MASSACHUSETTS
Goods and/or Services:
For: Pharmaceutical preparations for the prevention of cancerous tumors and other oncological diseases
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2026-01-27&serialNumber=99335856
Disclaimer: Curated by HT Syndication....